SCHEMBL4067812

SCHEMBL4067812

COC(=O)c1nc(-c2ccccc2)c2cccnc2c1OCc1ccc(OC)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.45
LMNA P02545 3/20 0.45
KDM4E B2RXH2 2/20 0.45
NPSR1 Q6W5P4 2/20 0.45
GAA P10253 1/20 0.45
KMT2A Q03164 1/20 0.45
RXFP1 Q9HBX9 1/20 0.43
EGLN1 Q9GZT9 1/20 0.43
HTT P42858 1/20 0.43
GABRA1 P14867 1/20 0.42
GABRG2 P18507 1/20 0.42
GABRB3 P28472 1/20 0.42
GABRA5 P31644 1/20 0.42
GABRA3 P34903 1/20 0.42
GABRA2 P47869 1/20 0.42
DNMT1 P26358 1/20 0.42
CKS1B P61024 1/20 0.42
SKP2 Q13309 1/20 0.42
PDE4A P27815 1/20 0.42
PDE4B Q07343 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4071451 0.85 KDM4E (0.46) ALDH1A1LMNAKDM4ENPSR1GAA
SCHEMBL4066434 0.85 KDM4E (0.52) ALDH1A1LMNAKDM4ENPSR1GAA
SCHEMBL4059013 0.85 KDM4E (0.47) ALDH1A1LMNAKDM4ENPSR1GAA
SCHEMBL4064203 0.82 KDM4E (0.46) ALDH1A1LMNAKDM4ENPSR1GAA
SCHEMBL1657008 0.79 LMNA (0.49) ALDH1A1LMNAKDM4ENPSR1GAA
SCHEMBL4065857 0.74 SMN1; SMN2 (0.39) ALDH1A1LMNAKDM4ENPSR1GAA
SCHEMBL13850913 0.72 LMNA (0.43) ALDH1A1LMNAKMT2AHPGDMAPT
SCHEMBL784068 0.72 RAB9A (0.60) ALDH1A1LMNAKDM4EKMT2AHTT
SCHEMBL1654008 0.72 KDM4E (0.44) ALDH1A1LMNAKDM4ENPSR1GAA
SCHEMBL31637037 0.72 LMNA (0.48) ALDH1A1LMNAKDM4ENPSR1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1326865-B1 AZA- AND POLYAZA-NAPHTHALENYL CARBOXAMIDES USEFUL AS HIV INTEGRASE INHIBITORS MERCK & CO INC (US) 2009-05-06 EP disclosed
US-20050176718-A1 Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors ANTHONY NEVILLE J (US) 2005-08-11 US disclosed
US-6921759-B2 Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors MERCK & CO., INC. (US) 2005-07-26 US disclosed
EP-1326865-A2 AZA- AND POLYAZA-NAPHTHALENYL CARBOXAMIDES USEFUL AS HIV INTEGRASE INHIBITORS Merck & Co., Inc. (US) 2003-07-16 EP disclosed
US-20030055071-A1 Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors MERCK SHARP & DOHME CORP. 2003-03-20 US disclosed
WO-2002030930-A2 AZA- AND POLYAZA-NAPHTHALENYL CARBOXAMIDES USEFUL AS HIV INTEGRASE INHIBITORS MERCK & CO., INC. (US) 2002-04-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030055071-A1 Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors POLI, DUT, NAAA ALDH1A1 2855/4885LMNA 1649/4885KDM4E 288/4885
US-20050176718-A1 Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors POLI, DUT, NAAA ALDH1A1 2855/4885LMNA 1649/4885KDM4E 288/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.